Corporate Venture Capital at DSM

The Life Sciences and Materials Sciences Company 23000 Employees; Global operations; 200 locations
2007 revenue x € million
Nutrition
Pharma

2,590
1,031 2,392

Performance Materials
Polymer Intermediates Base Chem. & Materials

1,475

1,284

Erik Rutten February 2009

DSM Venturing

DSM Venturing team

Erik Rutten Sr Investment Manager 24 years at DSM. R&D and Bus. Dev.
Marc Schüler, General Manager Venturing Yvonne Engelen, Senior Investment Manager Casper Bruens, Investment Manager/Manager LV Jinyue Wang, Venturing Manager China Kurt Du-Mong, Investment Manager Ian Freelance, Investment Manager Marcel Kloosterman, Senior Associate

University Twente (NL) Chemical Technology

DSM Venturing

Venturing is part of the Open Innovation Process
1a Market Scouting / Business Intelligence
2 Joint 4a Business Licensing Developments In

5 Venturing

1 Fuzzy Front End

6a Spin in

7a Acquisitions

1c. Interaction / Synthesis
7b Divestments

3 R&D services

4b Licensing Out

6b Spin out

1b Competence Development, Technology Intelligence 8 Intellectual Asset Management

DSM Venturing

Objectives : 1. Strategic, 2. Financial
1st filter: Strategic fit
1a: Does it fall within DSM’s knowledge base? 1b: Are there (potential) strategic benefits for business (who will ‘host’/support and why)?
yes

REJECT

2nd filter: VC criteria
2a: Is it a viable business proposition?
2b: Is there an attractive return potential? 2c: Are there exit opportunities other than spinning-in?

yes

DSM Venturing

INVEST

Strategic search areas for DSM Venturing
Performance Materials
NanoApplications Functional Coatings
Functional Materials

Biomedical Materials
BioMaterials

Life Science Pharma
Biopharmaceuticals Generics

Industrial Biotech
(Bio)Chemical Conversions and Processes Cosmeceuticals

Delivery/ Formulation

Personalized Nutrition

Life Science Food
Specialty Packaging
Nutraceuticals Dietary Supplements Vitamins

DSM Venturing

Current company stage scope
Sales

High Investment & Risk

Risk

0.5 – 15 MM$ 5 – 25% share Global presence DSM Venturing "Angels"
Public/PE

High

Sales

Grants

Financing gap

Venture Capital

Investment amounts

Low
Emerging Technology Proof of principle Commercialization Expansion

Low

Time

DSM Venturing

The Life Sciences and Materials Sciences Company

Thank you.
DSM Venturing

Sign up to vote on this title
UsefulNot useful